Short-term Prednisone to Treat STA Study(SPTSS)

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Efficiency and Safety Study of Short-term Prednisone to Treat Moderate and Severe Subacute Thyroiditis

The investigators hypothesize that less adverse reactions will be observed, comparing with the guidelines recommend. The recurrence rate, adrenal insufficiency, temporary and permanent hypothyroidism aren't significant difference.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xinqiao Hospital of Chongqing
• Treatments: Glucocorticoids; Prednisone

Criteria

Inclusion Criteria:

• 18-70 years patients with Moderate and severe subacute thyroiditis

Exclusion Criteria:

• adrenal cortical dysfunction,

• use of corticosteroids in nearly three months,

• mild subacute thyroiditis,

• non-onset STA,

• family history of diabetes,

• gastric ulcer,

• the special medication history,

• heart，liver and renal insufficiency,

• tumors,

• tuberculosis and

• poor compliance.